NCT 05215340 Brief Summary This study is designed to assess the efficacy…
Read more arrow_forwardNCT 06819735 Brief Summary This is a phase 1/2, dose-escalation and cohort-expansion…
Read more arrow_forwardNCT 05727176 Brief Summary This is an open-label, multinational, randomized Phase 2…
Read more arrow_forwardNCT 03947385 Brief Summary This is a Phase 1/2, multi-center, open-label basket…
Read more arrow_forwardNCT 04950075 Brief Summary Randomized, blinded, placebo-controlled, Phase 2 study of INBRX-109…
Read more arrow_forwardNCT 05427487 Brief Summary This is a Phase 1 open-label, non-randomized, multi-center…
Read more arrow_forwardNCT 05199753 Brief Summary This is a first-in-human, Phase I/II, open-label, multi-centre,…
Read more arrow_forwardNCT 05969041 Brief Summary MYE Symphony is a multicenter, open-label, Phase 1…
Read more arrow_forwardNCT 06784193 Brief Summary This is a first-in-human, open-label, multicenter phase 1…
Read more arrow_forwardNCT 02628067 Brief Summary In this study, participants with multiple types of…
Read more arrow_forward